GGrantIndex
← Search

TAS::75 0893::TAS THIOAPTAMER CAPTURE FOR ADDICTION-RELEVANT PROTEINS

$200,000N43FY2010DANIH

Am Biotechnologies, Llc, Houston TX

Investigators

Abstract

AM Biotechnologies (AM) will develop renewable thioaptamer protein capture reagents to ten proteins related to drug addiction. Thioaptamers are a type of aptamer containing phosphorodithioate linkages and other modifications that have excellent affinity and specificity for proteins. Because of the unique chemical composition of thioaptamers, they cannot be developed using the Systematic Evolution of Ligands by Exponential (SELEX) amplification method.

View original record on NIH RePORTER →